Biosimilars Litigation and Client Counseling
April 24, 2025
By: Aziz Burgy, Ricardo Camposanto, Darpan R. Singh
American Bar Association Section of Intellectual Property Law
Axinn partner Aziz Burgy and associates Ricardo Camposanto and Darpan Singh co-authored a chapter in the ABA Section of Intellectual Property Law publication, Biosimilars Litigation and Client Counseling.
Biosimilars Litigation and Client Counseling is a guide to the field of biologic products and biosimilars, as well as the laws governing them, most notably the Biologics Price Competition and Innovation Act.
Click here to access the publication.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Axinn Associates at the Antitrust Spring Meeting 2026: Sector-Specific Enforcement Trends
Axinn Viewpoints
Antitrust
Conspiracy Theories Newsletter, 2026 Edition
Byline Articles
Antitrust
Axinn Partners John Harkrider and Craig Minerva Win 2026 Concurrences Antitrust Writing Award
Awards & Recognitions
Antitrust
Axinn Wins Firm of the Year – Americas at 2026 Global Competition Review Awards
Awards & Recognitions
Antitrust
IPWatchdog Sixth Annual Live Conference
Speaking Engagement
Intellectual Property
Is Any Deal Safe From Review in the EU? Implications of the “Towercast” Judgment
Podcast
Antitrust
Axinn Antitrust Insight: HSR Overhaul: Out with the New, In with the Old
Axinn Viewpoints
Antitrust
The DOJ's Whistleblower Program and Leniency
Axinn Viewpoints
Antitrust